PATENTSCOPE will be unavailable a few hours for maintenance reason on Tuesday 19.11.2019 at 4:00 PM CET
Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (AU2017217350) Use of bacterial strains belonging to the species Lactobacillus kefiri in paediatrics to generate and/or maintain a state of homeostasis

Office : Australia
Application Number: 2017217350 Application Date: 09.02.2017
Publication Number: 2017217350 Publication Date: 17.08.2017
Publication Kind : A1
Prior PCT appl.: Application Number:IB2017050713 ; Publication Number: Click to see the data
IPC:
C12N 1/20
A23L 33/135
A61K 35/747
C12R 1/225
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
N
MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
1
Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
20
Bacteria; Culture media therefor
[IPC code unknown for A23L 33/135][IPC code unknown for A61K 35/747]
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
R
INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C-C12Q75
1
Micro-organisms
01
Bacteria or actinomycetales
225
Lactobacillus
CPC:
A61K 35/747
A23L 33/115
A23L 33/135
A23V 2002/00
A23Y 2220/47
A61K 9/145
A61K 9/5015
A61K 47/14
A61K 47/44
A61K 2035/115
C12N 1/20
C12R 1/225
Applicants: Hulka S.r.l.
Probiotical S.p.A.
Inventors:
Agents: Spruson & Ferguson
Priority Data: 102016000014907 12.02.2016 IT
102016000048058 10.05.2016 IT
Title: (EN) Use of bacterial strains belonging to the species Lactobacillus kefiri in paediatrics to generate and/or maintain a state of homeostasis
Abstract: front page image
(EN) The present invention relates to the use of bacterial strains belonging to the species Lactobacillus kefiri in paediatrics to generate and/or maintain the state of homeostasis. The present invention further relates to bacterial strains belonging to the species Lactobacillus kefiri having a high capacity to adhere to the intestinal epithelium; in particular, the present invention relates to the bacterial strains Lactobacillus kefiri LKF01 DSM 32079 LKEF and Lactobacillus kefiri LKF02 DSM 32080 for use in paediatrics. Finally, the present invention relates to a food composition, or a composition for a supplement, or a composition for a medical device, or a pharmaceutical composition (briefly all together the composition(s) of the present invention) comprising excipients and/or substances of a food or pharmaceutical grade formulation, and a mixture which comprises or, alternatively, consists of a bacterial strain selected from the group consisting of the bacterial strains belonging to the species Lactobacillus kefiri, said composition being for use in paediatrics to generate and/or maintain the state of homeostasis and for use in the preventive and/or curative treatment of inflammatory intestinal diseases, such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), Crohn's disease and ulcerative colitis (UC), in adult subjects, also in a chronic stage.
Also published as:
CA3013280CN108779433EP3414317BR112018016458US20190038682WO/2017/137920